Study guide

9.7 Returning & Reusing Drugs: Return-to-Stock, Donation & Disposal

Oklahoma MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 Oklahoma MPJE Format, Blueprint & Passing Standards 1.2 Navigating Oklahoma & Federal Pharmacy Law Hierarchy

2 Chapter 2: State Board Governance & Administrative Framework

2.1 Oklahoma State Board of Pharmacy Structure & Powers 2.2 Disciplinary Procedures, Sanctions & Hearings 2.3 Impaired Pharmacist Recovery Program & Duty to Report

3 Chapter 3: Pharmacist Licensure & Continuing Education

3.1 Pharmacist Licensure Qualifications & Examination Rules 3.2 Reciprocity & Foreign Pharmacy Graduates 3.3 Annual License Renewal & Continuing Education Mandates 3.4 Inactive Status, Late Renewal & License Reinstatement

4 Chapter 4: Pharmacy Interns, Preceptors & Supportive Personnel

4.1 Pharmacy Intern Qualifications & Preceptor Standards 4.2 Experiential Intern Hours, Credit & Board Reporting 4.3 Pharmacy Technician Permitting & Training Requirements 4.4 Pharmacist-to-Technician Ratios & Scope of Supportive Duties

5 Chapter 5: Prescription Validity & Prescriber Authority

5.1 Legal Requirements of a Valid Prescription 5.2 Prescriptive Authority & Scopes of Practice in Oklahoma 5.3 The Pharmacist's Corresponding Responsibility & Red Flags 5.4 Out-of-State, Military & Foreign Prescriptions

6 Chapter 6: Electronic Prescribing & Controlled Substance Schedules

6.1 Oklahoma Electronic Prescribing Mandate (EPCS) 6.2 Federal & Oklahoma Controlled Dangerous Substance Schedules 6.3 Scheduled Listed Chemical Products (SLCP) & Pseudoephedrine Sales 6.4 Schedule V Non-Prescription (Exempt) Controlled Substances

7 Chapter 7: Controlled Substance Dispensing & Opioid Limits

7.1 Schedule II Prescribing & Dispensing Regulations 7.2 Emergency Schedule II Oral Authorizations 7.3 Partial Filling of Schedule II Prescriptions (CARA & Title 63) 7.4 Oklahoma Opioid Prescribing Limits for Acute Pain

8 Chapter 8: Patient Counseling, Safety & Clinical Pharmacy Services

8.1 Patient Counseling Mandates & OBRA '90 8.2 Prospective Drug Utilization Review (DUR) Requirements 8.3 Pharmacist Immunization Administration Authority 8.4 Naloxone Standing Orders, Overdose Prevention & Clinical Protocols 8.5 Patient Confidentiality, HIPAA Privacy & Health-Record Protection

9 Chapter 9: Dispensing Standards, Generic Substitution & Labeling

9.1 Oklahoma Generic Drug Substitution Laws (Orange Book) 9.2 Biosimilar & Interchangeable Biological Products (Purple Book) 9.3 Prescription Refill Limits & Emergency Maintenance Fills 9.4 Prescription Labeling, Poison Prevention Packaging (PPPA) & USP Standards 9.5 Expired, Adulterated, Misbranded & Recalled Drug Products 9.6 Nonprescription Drug Labeling, Packaging & Repackaging 9.7 Returning & Reusing Drugs: Return-to-Stock, Donation & Disposal

10 Chapter 10: Prescription Transfers, Delivery & Monitoring Systems

10.1 Prescription Transfer Rules (Controlled vs. Non-Controlled) 10.2 Oklahoma Prescription Monitoring Program (OK PMP / PMP AWARxE) 10.3 Central Fill, Mail-Order & Prescription Delivery Regulations 10.4 Automated Dispensing Systems (ADS) & Remote Pharmacy Services

11 Chapter 11: Pharmacy Permits, Facilities & Operational Standards

11.1 Oklahoma Pharmacy Licenses & Permits 11.2 Pharmacist-in-Charge (PIC) Governance & Requirements 11.3 Physical Plant, Security & Sanitation Standards 11.4 Pharmacy Permanent Closing & Change of Ownership

12 Chapter 12: Controlled Substance Management, Ordering & Security

12.1 Pharmacy DEA & OBNDD Registration Requirements 12.2 Controlled Substance Ordering (DEA Form 222 & CSOS) 12.3 Controlled Substance Physical Inventory Requirements 12.4 Theft, Significant Loss & CDS Destruction (DEA Form 106 & Form 41)

13 Chapter 13: Compounding Standards & Institutional Practice

13.1 Non-Sterile (USP <795>) & Sterile (USP <797>) Compounding 13.2 Hazardous Drug Handling (USP <800>) 13.3 Hospital & Institutional Pharmacy Operations (Hospital Pharmacies & Drug Rooms) 13.4 Nuclear, Charitable & Specialty Pharmacy Standards

9.7 Returning & Reusing Drugs: Return-to-Stock, Donation & Disposal

Key Takeaways Explain This Topic AI

NABP competency 2.4 ("returning or reusing drugs") is a standalone sub-topic, and Oklahoma answers it through the Unused Prescription Drug Program in Title 59 O.S. rather than through a general return-to-stock rule.

Oklahoma's charitable pharmacy framework accepts donated unexpired non-controlled drugs for indigent patients; controlled dangerous substances are excluded from donation.

Product that has left the pharmacy's control cannot be returned to active dispensing stock, because the pharmacy can no longer attest to storage conditions — the product would be adulterated under FDCA § 501.

A pharmacy that is an authorized DEA collector may run a controlled substance take-back receptacle or mail-back program under 21 CFR Part 1317; collected substances are non-retrievable and are never returned to stock.

Last updated: August 2026

9.7 Returning & Reusing Drugs: Return-to-Stock, Donation & Disposal

Why this is tested: NABP Competency Statement 2.4 is a single line — "returning or reusing drugs" — but it carries its own weight inside the 33% Pharmacist Practice area. The question behind it is always the same: this product is in front of me and it is not going to the patient it was labeled for. What may lawfully happen to it?

1. The Governing Distinction: Did the Product Leave the Pharmacy's Control?

Everything in this topic turns on one line. +---------------------------------------------------------------------------+

  • | NEVER LEFT THE PHARMACY'S CONTROL |
  • | - Filled but never picked up (will-call return) |
  • | - Filled in error and caught before release |
  • | - Still in the manufacturer's sealed container in the department |
  • | => Storage conditions attestable => MAY be returned to stock |
  • +---------------------------------------------------------------------------+
  • | LEFT THE PHARMACY'S CONTROL |
  • | - Delivered to the patient, a caregiver, or a facility |
  • | - Shipped and then returned by the patient |
  • | => Storage conditions NOT attestable => MAY NOT go back into |
  • | dispensing stock; treat as adulterated under FDCA 501 |
  • +---------------------------------------------------------------------------+

The legal reason is not squeamishness — it is adulteration . FDCA § 501 makes a drug adulterated if it has been held under conditions whereby it may have been contaminated , or if its strength, quality, or purity differs from what it purports to have. Once a vial has been in a patient's car, kitchen, or bathroom, the pharmacy cannot attest to temperature, humidity, or tampering. Dispensing it to a second patient means dispensing a potentially adulterated drug.

Will-call returns — the routine case

Prescriptions filled but never picked up are the everyday application:

The product never left the department , so it may be returned to active stock.

The label must be removed or defaced so no patient-identifying information leaves with the product and no residual labeling misbrands it.

The dispensing must be reversed in the pharmacy system and, where billed, reversed with the payer.

If the product is a controlled dangerous substance , the return-to-stock must be reflected in the CDS accountability records, and the prescription record must show that the fill did not go to the patient. Because Oklahoma requires PMP transmission within five minutes of dispensing (OAC 475:45-1-5), a CDS return to stock also requires a PMP reversal so the repository does not carry a dispensation that never reached the patient. Failing to reverse the PMP entry leaves a false record in a database prescribers rely on.

2. Oklahoma's Unused Prescription Drug Program

Oklahoma has a statutory framework — the Unused Prescription Drug Program , in Title 59 of the Oklahoma Statutes — that creates a controlled exception for donation, rather than a general right to reuse.

Its architecture:

Element Rule

Who may receive donated drugs A charitable clinic pharmacy , separately licensed by the Board at a $75 fee (OAC 535:1-11-1(3)(B))

Who benefits Indigent and uninsured patients served by the charitable clinic

What may be donated Unexpired , non-controlled prescription drugs, in their original sealed packaging or unit-dose packaging with integrity intact

What may NOT be donated Controlled dangerous substances are excluded from the program

Who inspects A pharmacist must inspect donated product for expiration, adulteration, misbranding, and packaging integrity before it may be dispensed

PIC rule The general bar on serving as PIC of more than one pharmacy at a time does not apply to charitable pharmacies (OAC 535:15-3-2(b)(3))

Emergency medication kits An Oklahoma-licensed pharmacy may place an emergency medication kit in an Oklahoma facility remote site under 59 O.S. § 367.8(C) , at a $50 fee

Exam framing. A family brings in a deceased relative's unopened, unexpired blood-pressure medication and an unopened bottle of a Schedule II opioid, asking the pharmacy to "give them to someone who needs them." The non-controlled product may be routed into the donation program if the pharmacy participates and the packaging is intact; the Schedule II product may not be donated and should be directed to a DEA take-back pathway.

3. Disposal & Take-Back for Controlled Substances

Ultimate users cannot lawfully transfer controlled substances to a pharmacy for destruction unless the pharmacy is an authorized DEA collector under 21 CFR Part 1317 . A pharmacy that modifies its registration to become a collector may:

Maintain an on-site collection receptacle inside the pharmacy, located in an area regularly monitored by employees and not in the immediate area where controlled substances are stored;

Operate a mail-back program using DEA-approved packages;

Participate in DEA National Prescription Drug Take Back Day events.

Two rules govern the destination of collected product:

Collected substances must be rendered non-retrievable — permanently unavailable and unusable.

Collected product is never returned to dispensing stock , is not counted back into inventory, and is not inventoried by drug or quantity, because the collector may not inventory the contents of a receptacle liner.

For the pharmacy's own expired or unwanted controlled stock, the pathway is different: transfer to a reverse distributor and documentation on DEA Form 41 for destruction, as covered in section 12.4. Do not confuse Form 41 (registrant destruction) with Part 1317 collection (ultimate-user take-back). Non-controlled expired stock follows the Oklahoma six-month removal rule in OAC 535:15-3-11(c) — reverse distributor or return to supplier.

4. Long-Term Care Nuances

The LTC setting is where "returning or reusing drugs" produces the hardest fact patterns, because the product is dispensed to the facility rather than into a patient's home:

Medications supplied in unit-dose or blister (punch card) packaging that remain sealed have a stronger integrity argument than loose product in a vial, which is why LTC-servicing pharmacies package this way.

Emergency medication kits placed in facilities are pharmacy property; OAC 535:15-16 requires a record of transactions involving a controlled substance emergency kit to be maintained for two (2) years in a readily retrievable manner by the Oklahoma-licensed pharmacy and the facility — and the rule is explicit that this transaction record is separate from the prescription record, which must be kept a minimum of five years .

Kits that do not contain controlled dangerous substances may be maintained in an electronic system or a secure emergency medication kit, with a list of drugs attached (OAC 535:15-16).

5. Exam Decision Path

Is it a controlled dangerous substance? If yes: no donation; return to stock only if it never left the pharmacy, with CDS accountability and a PMP reversal ; otherwise route to a DEA collector, or to a reverse distributor with Form 41 if it is the pharmacy's own stock.

Did it leave the pharmacy's control? If yes: it may not go back into dispensing stock — treat it as adulterated.

Is it unexpired, non-controlled, and packaging-intact? Then the Unused Prescription Drug Program and a licensed charitable clinic pharmacy are the lawful reuse pathway, after pharmacist inspection.

Is it simply expired pharmacy stock? Apply OAC 535:15-3-11(c) : out of active inventory immediately, out of the pharmacy within six months , via reverse distributor or supplier return.